Status:
COMPLETED
Evaluation of Oxygen Delivery Methods in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
Ankara Etlik City Hospital
Conditions:
Chronic Obstructive Pulmonary Disease Exacerbation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To examine the effects of oxygen therapy methods applied as indicated in COPD acute exacerbations on blood gas results and spirometric measurements.
Detailed Description
Patients requiring non-invasive ventilation will be divided into two groups: one group will receive NIMV in the form of Continuous Positive Airway Pressure (CPAP) or Bi-level Positive Airway Pressure ...
Eligibility Criteria
Inclusion
- Patients with acute exacerbation of COPD,
- Those without a history of trauma,
- Patients who have not undergone any lung surgery previously,
- Patients capable of providing written and verbal consent.
Exclusion
- Patients without acute exacerbation of COPD,
- Pregnancy, suspected pregnancy,
- Those who have undergone any lung surgery previously,
- Patients with a history of trauma,
- Intubated patients and those not compliant with treatments,
- Patients unable to provide written and verbal consent.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06561464
Start Date
November 1 2023
End Date
June 1 2024
Last Update
October 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye), 38000